DekaBank Deutsche Girozentrale’s Dyne Therapeutics DYN Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio DYN Stock Details DYN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.07M	Hold	60,000	–	–	﹤0.01%	776
2026 Q1	$1.09M	Hold	60,000	–	–	﹤0.01%	776
2025 Q4	$1.86M	Hold	60,000	–	–	﹤0.01%	779
2025 Q3	$1.84M	Hold	60,000	–	–	﹤0.01%	765
2025 Q2	$1.85M	Hold	60,000	–	–	﹤0.01%	755
2025 Q1	$1.71M	Hold	60,000	–	–	﹤0.01%	758
2024 Q4	$1.62M	Hold	60,000	–	–	﹤0.01%	789
2024 Q3	$1.71M	Hold	60,000	–	–	﹤0.01%	788
2024 Q2	$1.71M	Hold	60,000	–	–	﹤0.01%	790
2024 Q1	$1.71M	Buy	60,000 +20,000	+50%	+$452K	﹤0.01%	790
2023 Q4	$526K	Hold	40,000	–	–	﹤0.01%	1027
2023 Q3	$352K	Hold	40,000	–	–	﹤0.01%	1092
2023 Q2	$417K	Buy	40,000 +25,000	+167%	+$295K	﹤0.01%	1059
2023 Q1	$174K	Hold	15,000	–	–	﹤0.01%	1201
2022 Q4	$171K	Buy	+15,000	New	+$174K	﹤0.01%	1241

Other funds holding DYN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Fiera Capital (Canada) Montreal, Quebec, Canada $27.6B AUM 23.56% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

DekaBank Deutsche Girozentrale's DYN Position: Q2 2026 in Review

DekaBank Deutsche Girozentrale held its Dyne Therapeutics (DYN) position steady in Q2 2026 at 60,000 shares worth $1.07M. The position accounts for ﹤0.01% of the portfolio, ranked #776.

DekaBank Deutsche Girozentrale first reported a position in DYN in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.86M in Q4 2025. 82 funds tracked by Wall St. Rank hold DYN as of Q2 2026.

DekaBank Deutsche Girozentrale held 60,000 shares of Dyne Therapeutics worth $1.07M as of Q2 2026.
DekaBank Deutsche Girozentrale left its Dyne Therapeutics share count unchanged in Q2 2026.
Dyne Therapeutics made up ﹤0.01% of DekaBank Deutsche Girozentrale's portfolio in Q2 2026, its #776 holding.
DekaBank Deutsche Girozentrale first reported a position in Dyne Therapeutics in Q4 2022 and has held it in 15 quarters since.
DekaBank Deutsche Girozentrale's Dyne Therapeutics position peaked at $1.86M in Q4 2025.
82 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q2 2026.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2026, filed 5 Aug 2026.